Notre Dame lost Jeremiyah Love & Jadarian Price, but return quarterback CJ Carr. Adding former OSU receivers Quincy Porter & Mylan Graham adds firepower.

During Mylan CEO Heather Bresch's 28-year stint there, the company has utterly transformed into a generics giant—and courted controversy along the way. And now, Bresch says she's stepping aside to ...

Mylan (MYL) CEO Heather Bresch got a rough reception from lawmakers in a hearing on Wednesday over the drugmaker’s steep price increases for its EpiPen anti-allergy product. Mylan has become ground ...

A months-long political and public firestorm over large drug price increases hasn’t been enough to bring the practice to a full stop. Now, Mylan ($MYL) is under the ...

As Mylan (MYL) was jacking up the price of EpiPens over the past two years, the drugmaker was also planning to boost something else: its top executives’ pay. In 2014, Mylan adopted a one-time ...

Mylan has struggled for a while with a challenging generic drug market, in the U.S. especially, weighing on its growth. The proposed transaction will combine Mylan with Upjohn, the Pfizer segment that ...

Jan 16 (Reuters) - Mylan has agreed to pay $73.5 million to settle a class action lawsuit by drug wholesalers accusing the drugmaker of scheming to overcharge them for EpiPen allergy treatment devices ...

Drugmaker Mylan said Monday that it will offer a generic version of the life-saving allergy treatment EpiPen for half the list price of the brand-name treatment after it became the center of a ...

Heather Bresch, CEO of embattled drug maker Mylan, testified before a House panel last week that one of the main reasons the company had to hike up the prices on its signature EpiPens from $100 to ...

Big drugmaker Mylan was slapped Monday with a class-action racketeering lawsuit that claims the company engaged in an illegal scheme to dramatically increase the list price of its EpiPen anti-allergy ...